Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Proto Labs (PRLB) EBT (2016 - 2025)

Proto Labs (PRLB) has disclosed EBT for 15 consecutive years, with $8.2 million as the latest value for Q4 2025.

  • Quarterly EBT rose 2990.78% to $8.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31.1 million through Dec 2025, up 25.9% year-over-year, with the annual reading at $31.1 million for FY2025, 25.9% up from the prior year.
  • EBT hit $8.2 million in Q4 2025 for Proto Labs, down from $10.3 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $16.2 million in Q2 2021 to a low of -$116.7 million in Q4 2022.
  • Historically, EBT has averaged $1.3 million across 5 years, with a median of $7.2 million in 2021.
  • Biggest five-year swings in EBT: plummeted 1002.44% in 2022 and later soared 2990.78% in 2025.
  • Year by year, EBT stood at $12.9 million in 2021, then tumbled by 1002.44% to -$116.7 million in 2022, then surged by 108.52% to $9.9 million in 2023, then plummeted by 102.84% to -$282000.0 in 2024, then skyrocketed by 2990.78% to $8.2 million in 2025.
  • Business Quant data shows EBT for PRLB at $8.2 million in Q4 2025, $10.3 million in Q3 2025, and $6.7 million in Q2 2025.